These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31579950)

  • 21. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions.
    Ahmed OM; Abd El-Tawab SM; Ahmed RG
    Int J Dev Neurosci; 2010 Oct; 28(6):437-54. PubMed ID: 20599606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.
    Zhu A; Yoneda T; Demura M; Karashima S; Usukura M; Yamagishi M; Takeda Y
    J Hypertens; 2009 Apr; 27(4):800-5. PubMed ID: 19516179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system].
    Rom-Bugoslavskaia ES; Komarova IV
    Probl Endokrinol (Mosk); 1986; 32(2):13-6. PubMed ID: 2424003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin-aldosterone system activity in hyperthyroid cats with and without concurrent hypertension.
    Williams TL; Elliott J; Syme HM
    J Vet Intern Med; 2013; 27(3):522-9. PubMed ID: 23517505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism.
    Kobori H; Ichihara A; Suzuki H; Takenaka T; Miyashita Y; Hayashi M; Saruta T
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H593-9. PubMed ID: 9277473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of aldosterone blockade.
    Weber MA
    Am Heart J; 2002 Nov; 144(5 Suppl):S12-8. PubMed ID: 12422136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric chronic hemodialysis patients - a pilot study.
    Shavit L; Neykin D; Lifschitz M; Slotki I
    Clin Nephrol; 2011 Nov; 76(5):388-95. PubMed ID: 22000559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin 1-7 Is a Negative Modulator of Aldosterone Secretion In Vitro and In Vivo.
    Shefer G; Marcus Y; Knoll E; Dolkart O; Foichtwanger S; Nevo N; Limor R; Stern N
    Hypertension; 2016 Aug; 68(2):378-84. PubMed ID: 27245181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.
    Ichikawa S; Takayama Y
    Hypertens Res; 2001 Nov; 24(6):641-6. PubMed ID: 11768722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone receptor antagonists: focus on eplerenone.
    Lamb RE; Folstad J
    Prog Cardiovasc Nurs; 2003; 18(1):54-9. PubMed ID: 12624573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Experimental Thyroid Dysfunction on Markers of Oxidative Stress in Rat Pancreas.
    Sajadian M; Hashemi M; Salimi S; Nakhaee A
    Drug Dev Res; 2016 Jun; 77(4):199-205. PubMed ID: 27241437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
    Brown JM; Williams JS; Luther JM; Garg R; Garza AE; Pojoga LH; Ruan DT; Williams GH; Adler GK; Vaidya A
    Hypertension; 2014 Feb; 63(2):273-80. PubMed ID: 24191286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High potassium promotes mutual interaction between (pro)renin receptor and the local renin-angiotensin-aldosterone system in rat inner medullary collecting duct cells.
    Xu C; Fang H; Zhou L; Lu A; Yang T
    Am J Physiol Cell Physiol; 2016 Oct; 311(4):C686-C695. PubMed ID: 27534754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of RAAS antagonist on the expression of gap junction cx43 in myocardium of spontaneously hypertensive rat].
    Tan LL; Li L; Liu LM; Zhao HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):531-5, 549. PubMed ID: 24059102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.
    Balogh DB; Molnar A; Degi A; Toth A; Lenart L; Saeed A; Barczi A; Szabo AJ; Wagner LJ; Reusz G; Fekete A
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.